Ahead of next week's third-quarter financial results, Pfizer Inc.'s board of directors declared Thursday a 22-cent fourth-quarter dividend on the company's common stock.
The dividend was unchanged from previous quarters this year. It is payable Dec. 4 to shareholders of record at the close of business on Nov. 9.
The dividend will be the 296th consecutive quarterly cash payout by Pfizer, whose stock price is currently near a five-year high.
A 10 percent dividend increase and $10 billion stock buyback program was announced at the end of last year. Pfizer cut its dividend in half in 2009 but has been raising payouts since.